Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05013138 · ClinicalTrials.gov registry record · NA
Caregiver Adverse Childhood Experiences (ACEs) in Pediatric Primary Care
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 181
- Enrollment target
NCT05013138: Completed NA study, sponsored by Emory University.
NCT05013138 is a NA study that has completed, run by Emory University. The registered enrollment target is 181 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05013138, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 181 participants
- Enrollment target
Study Summary
This longitudinal study will evaluate if increased caregiver awareness of their own ACEs through provider-led discussions will lead to improved child health via fewer emergency department, urgent care visits and missed primary care appointments.
Primary Outcome
Number of emergency department (ED) visits documented in chart from baseline to 18 months post-intervention
Interventions
- BEHAVIORAL Training for ACEs and study procedures
- BEHAVIORAL Training on study procedures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2022-04-29 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
What the finished NCT05013138 record still lists
NCT05013138 is an interventional study that assigns participants to a tested intervention. The registered 181 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Training for ACEs and study procedures is the first listed.
NCT05013138 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05013138 about?
NCT05013138 is a clinical study titled "Caregiver Adverse Childhood Experiences (ACEs) in Pediatric Primary Care". This longitudinal study will evaluate if increased caregiver awareness of their own ACEs through provider-led discussions will lead to improved child health via fewer emergency department, urgent care visits and missed primary care appointments.
What is the current status of trial NCT05013138?
This trial is currently completed. It is a NA study. The enrollment target is 181 participants. The study started on 2022-04-29. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT05013138?
The interventions under investigation include: Training for ACEs and study procedures (BEHAVIORAL), Training on study procedures (BEHAVIORAL).
Who is sponsoring clinical trial NCT05013138?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05013138's enrollment target sits among peer trials
181 586th of 2000 higher than 1,415 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04578392 · 181 participants · NA
MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)
- NCT05597891 · 181 participants · NA
Endovascular Engineering ENGULF Study
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI